natural killer T cells

San Diego biotech Glycoregimmune raises $4.3 million for natural killer T cell-based therapy

San Diego biotech Glycoregimmune is working on a way to inhibit the natural killer T cells that exacerbate the inflammatory response and hepatic injury that stems from liver disease. Natural killer T cells are a sort of heterogenous variety of immune cell; the company says: NKT cells share properties of both NK and T cells and are a […]

By Meghana Keshavan

Physicians

OmniLife Health’s Clinical Workflow Solution Focuses on Complex Care

OmniLife Health's initial focus with its complex care coordination platform is organ transplant care.

Health Tech

HealthBook+ CEO Shares Vision for How People Can Own Their Health by Leveraging Data and AI

HealthBook+ provides a way for individuals to aggregate and use their personal health information safely and securely to power AI engines that direct people to their next best health action. Importantly, it also gives employers predictive insights to help them provide the most relevant benefits for their employees.